Book contents
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Part II Stimulant Drugs
- Part III Depressant Drugs
- Chapter 12 Depressant Drugs: Introduction
- Chapter 13 Depressant Drugs: Gamma-Hydroxybutyrate (GHB) and Gamma-Butyrolactone (GBL)
- Chapter 14 Depressant Drugs: Fentanyl, Fentanyl Analogues and Other Opioid NPS
- Chapter 15 Depressant Drugs: Benzodiazepine NPS
- Chapter 16 Depressant Drugs: Ketamine and Its Analogues
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Chapter 15 - Depressant Drugs: Benzodiazepine NPS
from Part III - Depressant Drugs
Published online by Cambridge University Press: 21 September 2020
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Part II Stimulant Drugs
- Part III Depressant Drugs
- Chapter 12 Depressant Drugs: Introduction
- Chapter 13 Depressant Drugs: Gamma-Hydroxybutyrate (GHB) and Gamma-Butyrolactone (GBL)
- Chapter 14 Depressant Drugs: Fentanyl, Fentanyl Analogues and Other Opioid NPS
- Chapter 15 Depressant Drugs: Benzodiazepine NPS
- Chapter 16 Depressant Drugs: Ketamine and Its Analogues
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Summary
Many of these uncontrolled benzodiazepine-type substances were NPS. However, in comparison to other types of NPS that have appeared in the last decade, the number of benzodiazepine NPS is small. The World Drug Report 2019 noted that out of the 492 drugs classified as NPS that were reported in 2017, only 25 were NPS with a sedative-hypnotic effect. Among all NPS reported in 2017, 79 were reported for the first time this year, and this only included 4 drugs with a sedative-hypnotic effect. Most such NPS are benzodiazepines, some of which have been patented, but many have never been marketed for medical use. The majority have never undergone clinical trials and are typically sold as ‘legal benzodiazepines’, ‘designer benzodiazepines’ or ‘research chemicals’.
- Type
- Chapter
- Information
- Club Drugs and Novel Psychoactive SubstancesThe Clinician's Handbook, pp. 78 - 80Publisher: Cambridge University PressPrint publication year: 2020